INNOVANCE® PFA-200 System
Fast and reliable platelet dysfunction detection.
Receive your quote directly from the manufacturer.
Are you providing fast and reliable detection platelet dysfunction? The INNOVANCE ® PFA-200 System* provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction. It measures the process of primary hemostasis and aids in the rapid detection of platelet dysfunction.
- Through flow technology, the system provides a realistic hemodynamic environment for the measurement of primary hemostasis.
- Screens platelet function in patients with impaired primary hemostasis, such as von Willebrand disease Provides excellent sensitivity for congenital platelet dysfunction, such as Glanzmann thrombasthenia Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients.
- Assesses platelet dysfunction due to the effect of aspirin Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia Detects platelet P2Y12-receptor blockades in patients undergoing therapy with P2Y12-receptor antagonists
The INNOVANCE PFA-200 System provides simple, rapid, qualitative, and precise automated assessment of platelet function and supports clinically relevant decision-making processes effecting therapies. The system quickly measures platelet plug formation in a small whole blood sample (800 μL) and reports a ”closure time” in 5–8 minutes.
For full product information use the product website link below, or visit www.siemens.co.uk/diagnostics
*Not available for sale in the U.S. Product availability varies by country. Not available in the UK.
Antithrombin blood test from Siemens Healthineers now FDA cleared as a companion diagnostic for Qfitlia, a Sanofi hemophilia therapy
Measuring antithrombin activity levels helps people receive the appropriate dose, initially and over time
